Thus, increasing both glucagon-like peptide 1 secretion and adiponectin production by omega-3 fatty acids could improve both insulin secretion and sensitivity [62] resulting in improved recovery from insulin resistance and dyslipidemia, thus attenuating metabolic syndrome. The gene discussed is INS; the disease is Insulin resistance.